|
Information was received from healthcare provider (hcp) via a manufacturer representative regarding a patient having oblique lumbar interbody fusion procedure at l2-5 for spinal canal stenosis.It was reported that the cage was damaged during insertion at l4/5, and it was determined that complete fragment removal would be difficult; hence, fragments reportedly remained in the patient.The treatment was changed to iliac bone grafting and rear fixation, and the procedure was delayed by more than 60 minutes.No further complications were reported in relation to the event.Additional information was received that a broken fragment of part of the damaged cage remained in the body.At the time of insertion, the intervertebral space was narrow and, at l4/5, the ilium was obstructing.
|
|
E1: initial reporter is unknown.B2: outcome attributed to adverse event is additional surgery.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|